The relationship between the gut microbiome and neurodegenerative diseases
This 2021 study focuses on the association between the gut microbiome and neurodegenerative diseases. The microbiome living in our guts play important roles in human physiology and pathology, which has led to microbiome-based approaches for enhancing health and treating diseases. Researchers have tried to determine the relationship between gut microbiome and neurodegenerative and aging diseases (such as Alzheimer’s, Parkinson’s disease) but the exact interactions between these two remain unclear. Hopefully, the interrelations will be confirmed as technology advances and new study techniques will be developed. This article presents the currently known aspects of the connection between gut microbiome and neurodegenerative diseases. For instance, the author discusses the potential therapeutic role of microbiome-based therapies in diseases. [NPID: gut microbiota, microbiome, neurodegenerative diseases, Alzheimer’s, parkinson’s, parkinsons, alzheimers]
Year: 2021
Reference: Zhu, X., Li, B., Lou, P., Dai, T., Chen, Y., Zhuge, A., Yuan, Y., & Li, L. (2021). The Relationship Between the Gut Microbiome and Neurodegenerative Diseases. Neuroscience bulletin, 37(10), 1510–1522. https://doi.org/10.1007/s12264-021-00730-8
Related Studies
The system of brain-gut microbiota (BGM) has a major impact on mental health. In this work, An et al. (2024) used multimodal magnetic resonance imaging and fecal samples to investigate BGM patterns linked to resilience. The authors found that individuals with high resilience exhibited a reduction in the symptoms of depression and anxiety. Additionally, they […]
Although the exact processes are yet unknown, probiotic administration has been demonstrated to improve athletes’ body composition and endurance performance. Athletes’ gut microbiota can offer quantifiable indicators of immunological function, and microbial composition analysis may aid in the identification of exercise-induced stress and metabolic problems. In this double-blind controlled trial by Want et al. (2024), […]